These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35883517)

  • 1. Untargeted Metabolomic Plasma Profiling of Emirati Dialysis Patients with Diabetes versus Non-Diabetic: A Pilot Study.
    Banimfreg BH; Alshraideh H; Shamayleh A; Guella A; Semreen MH; Al Bataineh MT; Soares NC
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the "gut-kidney axis".
    Han C; Shen Z; Cui T; Ai SS; Gao RR; Liu Y; Sui GY; Hu HZ; Li W
    J Ethnopharmacol; 2023 May; 307():116257. PubMed ID: 36787845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic profiling of amino acids study reveals a distinct diagnostic model for diabetic kidney disease.
    Wang J; Zhou C; Zhang Q; Liu Z
    Amino Acids; 2023 Nov; 55(11):1563-1572. PubMed ID: 37736814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Zhuang medicine compound Xiancao Granule on diabetic kidney disease: A multi-omics analysis.
    Mo C; Zhao J; Liang J; Chen Y; Wang H; Dai Y; Huang G
    J Ethnopharmacol; 2024 Mar; 321():117517. PubMed ID: 38042391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical metabolomics characteristics of diabetic kidney disease: A meta-analysis of 1875 cases with diabetic kidney disease and 4503 controls.
    Yuan Y; Huang L; Yu L; Yan X; Chen S; Bi C; He J; Zhao Y; Yang L; Ning L; Jin H; Yang R; Li Y
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3789. PubMed ID: 38501707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Untargeted approach to investigating the metabolomics profile of type 2 diabetes emiratis.
    Banimfreg BH; Shamayleh A; Alshraideh H; Semreen MH; Soares NC
    J Proteomics; 2022 Oct; 269():104718. PubMed ID: 36100153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT2 inhibitors improve kidney function and morphology by regulating renal metabolic reprogramming in mice with diabetic kidney disease.
    Lu YP; Zhang ZY; Wu HW; Fang LJ; Hu B; Tang C; Zhang YQ; Yin L; Tang DE; Zheng ZH; Zhu T; Dai Y
    J Transl Med; 2022 Sep; 20(1):420. PubMed ID: 36104729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease.
    Jiang X; Liu X; Qu X; Zhu P; Wo F; Xu X; Jin J; He Q; Wu J
    Theranostics; 2023; 13(10):3188-3203. PubMed ID: 37351171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UPLC-MS-based urine nontargeted metabolic profiling identifies dysregulation of pantothenate and CoA biosynthesis pathway in diabetic kidney disease.
    Ma T; Liu T; Xie P; Jiang S; Yi W; Dai P; Guo X
    Life Sci; 2020 Oct; 258():118160. PubMed ID: 32730837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic profiling and correlations with clinical features reveal biomarkers indicative of diabetic retinopathy with diabetic kidney disease.
    Fan X; Xu M; Chen X; Ren Q; Fan Y; Wang R; Chen J; Cui L; Wang Z; Sun X; Guo N
    Front Endocrinol (Lausanne); 2022; 13():1001391. PubMed ID: 36277688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry.
    Lin HT; Cheng ML; Lo CJ; Lin G; Liu FC
    Diagnostics (Basel); 2022 Oct; 12(11):. PubMed ID: 36359470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease.
    Zhang T; Wang X; Zhang Y; Yang Y; Yang C; Wei H; Zhao Q
    J Transl Med; 2023 Jun; 21(1):381. PubMed ID: 37308973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics analysis reveals the potential pathogenesis and therapeutic targets of diabetic kidney disease.
    Wei L; Gao J; Wang L; Tao Q; Tu C
    Hum Mol Genet; 2024 Jan; 33(2):122-137. PubMed ID: 37774345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
    Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
    Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study.
    Zhang H; Zuo JJ; Dong SS; Lan Y; Wu CW; Mao GY; Zheng C
    J Diabetes Res; 2020; 2020():3049098. PubMed ID: 32190695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Amino Acid Metabolism and Its Correlation with Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Zhu H; Bai M; Xie X; Wang J; Weng C; Dai H; Chen J; Han F; Lin W
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary serum and fecal metabolomics study of spontaneously diabetic cynomolgus monkeys based on LC-MS/MS.
    Tian C; Qiu M; Lv H; Yue F; Zhou F
    J Med Primatol; 2022 Dec; 51(6):355-366. PubMed ID: 35993379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Urinary Metabolite Biomarkers of Type 2 Diabetes Nephropathy Using an Untargeted Metabolomic Approach.
    Chen CJ; Liao WL; Chang CT; Lin YN; Tsai FJ
    J Proteome Res; 2018 Nov; 17(11):3997-4007. PubMed ID: 30265543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease.
    Huang G; Li M; Li Y; Mao Y
    Lab Med; 2022 Nov; 53(6):545-551. PubMed ID: 35748329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism.
    Rong G; Weng W; Huang J; Chen Y; Yu X; Yuan R; Gu X; Wu X; Cai Y; Han P; Shao M; Sun H; Ge N
    Biomed Res Int; 2022; 2022():7339611. PubMed ID: 35601149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.